NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)

archived

Purpose. This Funding Opportunity Announcement (FOA), issued by the NIAMS, National Institutes of Health, solicits applications for research awards designed to develop and evaluate new clinical trial outcomes measures to assess the adverse events, and the link between efficacy and effectiveness of therapies employed to treat diseases, illnesses and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and initial evaluation of new clinically-relevant and patient-important outcome measures and instruments that could be further tested with existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, treatment or cure of diseases, illnesses and injuries of interest to the NIAMS. Mechanism of Support. This FOA will utilize the U01 cooperative agreement grant mechanism. Funds Available and Anticipated Number of Awards. The NIAMS intends to commit approximately $1.0 million in FY 2010 to fund four or five new grants in response to this FOA. These awards are not renewable.

High